[Pyridoxal coenzyme content in the tissues of irradiated animals as affected by adrenoblockaders in in vitro experiments].
D000317:Adrenergic alpha-Antagonists / Q000494:pharmacology*; D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000528:radiation effects; D003067:Coenzymes / Q000528:radiation effects*; D006321:Heart / Q000528:radiation effects; D066298:In Vitro Techniques; D008099:Liver / Q000528:radiation effects; D009943:Organophosphorus Compounds / Q000528:radiation effects; D011730:Pyridoxal / Q000528:radiation effects*; D011732:Pyridoxal Phosphate / Q000528:radiation effects; D011733:Pyridoxamine / Q000031:analogs & derivatives / Q000528:radiation effects; D051381:Rats; D011919:Rats, Inbred Strains
D000317:Adrenergic alpha-Antagonists; D000319:Adrenergic beta-Antagonists; D003067:Coenzymes; D009943:Organophosphorus Compounds; D011730:Pyridoxal; D011732:Pyridoxal Phosphate; D011733:Pyridoxamine; C010627:pyridoxamine phosphate
Soderzhanie piridoksalevykh kofermentov v tkaniakh obluchennykh zhivotnykh pod vliianiem adrenoblokatorov v opytakh in vitro.